beauvericin has been researched along with Necrosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Font, G; Juan-García, A; Prosperini, A; Ruiz, MJ | 1 |
Chovolou, Y; Debbab, A; Hohlfeld, A; Proksch, P; Wätjen, W | 1 |
Font, G; Juan-García, A; Manyes, L; Ruiz, MJ | 1 |
Colvin, KL; Cook, JL; Routes, BA; Routes, JM; Walker, TA | 1 |
4 other study(ies) available for beauvericin and Necrosis
Article | Year |
---|---|
Beauvericin-induced cytotoxicity via ROS production and mitochondrial damage in Caco-2 cells.
Topics: Apoptosis; Caco-2 Cells; Cell Survival; Depsipeptides; DNA Damage; G2 Phase; Glutathione; Humans; Inhibitory Concentration 50; Intestinal Mucosa; Ionophores; Kinetics; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mitochondria; Mycotoxins; Necrosis; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2013 |
The mycotoxin beauvericin induces apoptotic cell death in H4IIE hepatoma cells accompanied by an inhibition of NF-κB-activity and modulation of MAP-kinases.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Depsipeptides; Dose-Response Relationship, Drug; Enzyme Activation; HCT116 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; Mycotoxins; Necrosis; NF-kappa B; Phosphorylation; Protein Kinase Inhibitors; Rats; Signal Transduction; src-Family Kinases; Time Factors | 2014 |
Enniatin A1, enniatin B1 and beauvericin on HepG2: Evaluation of toxic effects.
Topics: Apoptosis; Cell Cycle; Cell Proliferation; Depsipeptides; Fusarium; Hep G2 Cells; Hepatocytes; Humans; Kinetics; Membrane Potential, Mitochondrial; Mycotoxins; Necrosis; Stereoisomerism | 2015 |
E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury.
Topics: 3T3 Cells; Adenovirus E1A Proteins; Adenoviruses, Human; Animals; Anti-Bacterial Agents; Apoptosis; Cell Death; Cell Transformation, Viral; Cricetinae; Cytotoxicity, Immunologic; Depsipeptides; E1A-Associated p300 Protein; Humans; Killer Cells, Natural; Mice; Mutation; Necrosis; Nuclear Proteins; Peptides; Rats; Sarcoma, Experimental; Trans-Activators | 1999 |